Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane for cerebral perfusion in subarachnoid hemorrhage
NCT05213832Phase 2Completed
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of isoflurane in subarachnoid hemorrhage (SAH), sponsored by AOU Città della Salute e della Scienza di Torino. Started Jun 2020; status: completed.
02
Drugs
isoflurane
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT05213832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05213832.